Cargando…
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive neoplasm of the pleura, mainly related to asbestos exposure. As in other solid tumors, malignant cells exhibit high glucose uptake and glycolytic rates with increased lactic acid efflux into the interstitial space. Lactate transport i...
Autores principales: | Dell’Anno, Irene, Barone, Elisa, Mutti, Luciano, Rassl, Doris M., Marciniak, Stefan J., Silvestri, Roberto, Landi, Stefano, Gemignani, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650278/ https://www.ncbi.nlm.nih.gov/pubmed/32887638 http://dx.doi.org/10.1186/s12967-020-02487-6 |
Ejemplares similares
-
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2022) -
EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021) -
Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)